CG
AMED

Caprock Group’s Amedisys AMED Stock Holding History

Caprock Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-926
Closed -$227K – 535
2021
Q2 		$227K Sell
926
-7
-0.8% -$1.84K 0.02% 464
2021
Q1 		$247K Sell
933
-12
-1% -$3.38K 0.03% 398
2020
Q4 		$277K Buy
945
+45
+5% +$11.5K 0.03% 349
2020
Q3 		$213K Buy
+900
New +$205K 0.03% 357
2020
Q2 		– Sell
-1,300
Closed -$239K – 421
2020
Q1 		$239K Hold
1,300
– – 0.05% 282
2019
Q4 		$217K Buy
+1,300
New +$193K 0.04% 314

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caprock Group's AMED Position: Q3 2021 in Review

Caprock Group sold out of Amedisys (AMED) in Q3 2021, closing a stake of 926 shares — an estimated $227K sold.

Caprock Group first reported a position in AMED in Q4 2019 and held it in 6 quarters. The position peaked at $277K in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Caprock Group reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Caprock Group sold 926 Amedisys shares in Q3 2021, an estimated $227K.
  • Caprock Group first reported a position in Amedisys in Q4 2019 and held it in 6 quarters.
  • Caprock Group's Amedisys position peaked at $277K in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Caprock Group's 13F filing for Q3 2021, filed 7 Oct 2021.